315 results on '"Mousses, Spyro"'
Search Results
2. Comprehensive Copy Number and Gene Expression Profiling of the 17q23 Amplicon in Human Breast Cancer
3. Abstract 4417: Activity of novel RNA therapeutics to overcome resistance to immune checkpoint blockade
4. Supplementary Figure 2 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
5. Supplementary Table 9 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
6. Supplementary Figure 1 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
7. Supplementary Table 4 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
8. Supplementary Table 3 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
9. Supplementary Table 5 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
10. Data from High-throughput RNAi Screening Identifies a Role for TNK1 in Growth and Survival of Pancreatic Cancer Cells
11. Supplementary Table 8 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
12. Supplementary Table 2 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
13. Supplementary Table 7 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
14. Supplementary Table 1 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
15. Supplementary Figure 3 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
16. Supplementary Tables 1-3, Figures 1-4 from High-throughput RNAi Screening Identifies a Role for TNK1 in Growth and Survival of Pancreatic Cancer Cells
17. Data from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
18. Supplementary Table 6 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
19. Supplementary Table 2 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
20. Data from Identification of Molecular Vulnerabilities in Human Multiple Myeloma Cells by RNA Interference Lethality Screening of the Druggable Genome
21. Supplementary Table 1 from Identification of Molecular Vulnerabilities in Human Multiple Myeloma Cells by RNA Interference Lethality Screening of the Druggable Genome
22. Supplementary Table 1 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
23. Supplementary Table 4 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
24. Supplementary Table 3 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
25. Supplementary Table 5 from Intersex-like (IXL) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification
26. Genetic Predisposition to Symptomatic Lumbar Disk Herniation in Pediatric and Young Adult Patients
27. Microarray (cDNA) Technology
28. The Application of High-Throughput RNAi in Pancreatic Cancer Target Discovery and Drug Development
29. Gene Silencing through RNA Interference : Potential for Therapeutics and Functional Genomics
30. Application of Microarray Technologies for Translational Genomics
31. Abstract 4096: Development of novel anticancer RNA therapeutics with dual-targeting siRNA that silences ubiquitin family members
32. Abstract 4239: Development of multi-targeting immunomodulatory SeekR RNA therapeutics to overcome resistance to PD-1 blockade
33. Abstract 4081: Leveraging single-cell RNA sequencing data to design multi-targeting SeekRRNA therapeutics
34. Microarray (cDNA) Technology
35. Advancing a clinically relevant perspective of the clonal nature of cancer
36. RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5
37. Microarray (cDNA) Technology
38. Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6
39. Microarray (cDNA) Technology
40. A small-molecule activator of the unfolded protein response eradicates human breast tumors in mice
41. Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes
42. Analysis and Visualization of Gene Expression Microarray Data in Human Cancer Using Self-Organizing Maps
43. Gene silencing through RNA interference: Potential for therapeutics and functional genomics
44. The BioIntelligence Framework: a new computational platform for biomedical knowledge computing
45. Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling
46. RNAi-Based Functional Pharmacogenomics
47. High-Throughput siRNA Screening as a Method of Perturbation of Biological Systems and Identification of Targeted Pathways Coupled with Compound Screening
48. Kinome-wide siRNA screening identifies molecular targets mediating the sensitivity of pancreatic cancer cells to Aurora kinase inhibitors
49. Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer
50. Genome scale cytometry: High content analysis for high throughput RNAi phenotype profiling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.